Please upgrade your browser.
C-reactive protein (CRP) is considered a useful serum marker for patients with RCC. However, its clinical utility in advanced metastatic renal cell carcinoma (AM-RCC), particularly in deciding whether to perform nephrectomy at the onset, is not well studied.
The aim of this study was to evaluate the use of sunitinib as third-line therapy for metastatic renal cell carcinoma (mRCC).
Adaptation to low oxygen by changing gene expression is vitally important for cell survival and tissue development. The sprouting of new blood vessels, initiated from endothelial cells, restores the oxygen supply of ischemic tissues.
The link may be attributed to abnormal stress hormone regulation and inflammatory gene expression, researchers from the University of Texas M.D. Anderson Cancer Center reported in the Aug. 1 edition of PLoS ONE.
Every cancer patient who is diagnosed at CAMC or receives treatment at its hospitals is entered into a computer database.
Isabel Doran is only 4 years old, but she's already had about 15 CT scans â and every one comes with a dose of radiation.
International kidney cancer charity earns fifth consecutive Charity Navigator 4-star rating
Check out Gorjana and Griffin's custom necklace -- 50% of proceeds go to KCA!
esearchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction.
To evaluate the prognostic impact of the histological expression of CD133 in renal cell carcinoma (RCC).
|Powered by NeonCRM|